MedVi vs Willow: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and Willow: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and Willow are two established telehealth providers offering GLP-1–based weight management programs. This article compares MedVi vs Willow to help you identify which best fits your goals and preferences.
MedVi vs Willow: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month (Code: ) | — No |
| Willow | $299.00 | $399.00 | Best for Oral and Injectable (Code: ) | — No |
MedVi vs Willow: Medical Process & Accessibility
MedVi focuses on a rapid telehealth intake that typically completes within 24‑48 hours. After a brief online questionnaire, a licensed clinician reviews the information, confirms eligibility, and can issue a prescription the same day if all criteria are met. Willow, on the other hand, emphasizes a more structured onboarding experience that includes a video consultation, a detailed medical history review, and a baseline lab panel (if recommended). Both services are fully virtual, allowing you to start the process from any U.S. state where telehealth prescribing of GLP‑1 medications is permitted.
MedVi vs Willow: Pricing Comparison
MedVi starts semaglutide at $179.00 and tirzepatide at $279.00, while Willow begins at $299.00 and $399.00 respectively. Because the lower price for each medication is highlighted in bold, you can quickly see that MedVi offers the more affordable option for both drugs.
Both providers also promote introductory savings. MedVi advertises “$120 off first month,” which is automatically applied at checkout (no promo code required). Willow’s marketing emphasizes that its program is “Best for Oral and Injectable” but does not list a dollar‑value discount; the benefit is reflected in its comprehensive support model rather than a direct price cut.
MedVi vs Willow: Clinical Oversight & Support
Both platforms provide access to board‑certified physicians, nurse practitioners, or physician assistants who specialize in metabolic health. MedVi’s model is streamlined: after the initial intake, clinicians may approve the prescription with minimal follow‑up, and patients receive automated text reminders for refills. Willow, however, integrates scheduled tele‑visits every 4–6 weeks to assess weight loss progress, side‑effect management, and dose titration. This ongoing interaction can be valuable for individuals who anticipate needing more hands‑on guidance.
Book a Consultation with MedVi
MedVi vs Willow: Medication Quality & Safety
Both companies partner with FDA‑registered compounding pharmacies located in the United States. The GLP‑1 products are compounded versions of semaglutide and tirzepatide, which means they are formulated under strict Good Manufacturing Practice (GMP) standards and are prescribed only after a clinician verifies your medical suitability. While these compounds are not the brand‑name products Wegovy® or Mounjaro®, they contain the same active ingredient and have been shown in clinical practice to produce comparable weight‑loss outcomes when used correctly.
MedVi vs Willow: Customer Experience
Patient testimonials frequently cite MedVi’s affordability and speed of service as top strengths. Many users report receiving their medication within 3–5 business days after approval. Willow’s reviewers often highlight the thoroughness of the clinical team, noting that regular check‑ins help them stay on track and manage any gastrointestinal side effects that can accompany GLP‑1 therapy.
MedVi vs Willow: Final Verdict
If cost and a swift start are your primary concerns, MedVi is the clear winner, offering the lowest entry‑level prices for both semaglutide and tirzepatide and a $120 discount on the first month. If you prefer a program that includes scheduled physician‑led follow‑ups, personalized dose adjustments, and a stronger emphasis on oral‑formulation options, Willow may be the better fit.
Both providers comply with telehealth regulations, use licensed U.S. pharmacies, and require a prescription from a qualified clinician before dispensing medication. Your choice should align with your budget, desired level of clinical interaction, and personal comfort with the telehealth workflow.
Join MedVi
Get Started with Willow
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Starts at $146/mo (6‑month plan)
- Affordable Semaglutide injections
- Klarna / AfterPay / Affirm supported
- Personalized dosing to reach goals
From $179 + free FedEx
- Approval within ~4 hours*
- Semaglutide & Tirzepatide available
- Price‑lock: same price any dose
Free consult ($75 value)
- GLP‑1 ID Protocol — 46% faster*
- 4.9★ Google & Trustpilot
- No‑obligation evaluation
$120 OFF First Month
- GLP‑1 meds delivered to your door
- Refund if you don’t lose weight
- Doctor‑approved, U.S. clinicians
Save $70 (Code: Explore)
- Ozempic®, Tirzepatide & Semaglutide
- Instant approval, ship ≤ 3 days
- No membership fees
From $155/mo (12‑month plan)
- No insurance or membership required
- Quick approval — no waitlist
- Brand & compounded available
$50 Off First Month
- 2‑minute quiz, $50 off month one
- Prescription in ≤ 24 hours
- Cancel or change anytime
Pay $199 first month
- Free overnight shipping
- Avg. 14% weight loss*
- No insurance needed
$120 OFF First Month
- Affordable access to treatments
- Doctor‑supervised programs
- Clear pricing
$50 OFF First Month
- Streamlined treatment process
- Holistic program
- Mobile‑friendly platform
.png)
Programs available
- 100% online evaluation
- Provider messaging & check‑ins
- Fast‑track programs
From $249 / month
- Certified GLP‑1 providers
- Licensed consultations
- Nationwide coverage